NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.590
+0.040 (1.57%)
Mar 27, 2026, 10:47 AM EDT - Market open
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $298.6 million as of March 27, 2026. Its market cap has increased by 349.91% in one year.
Market Cap
298.60M
Enterprise Value
68.99M
1-Year Change
349.91%
Ranking
Category
Stock Price
$2.59
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $298.60M, an increase of 116.31%. That is a compound annual growth rate of 13.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 26, 2026 | 293.99M | -35.93% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Avalo Therapeutics | 306.50M |
| Polaryx Therapeutics | 304.89M |
| Armata Pharmaceuticals | 298.27M |
| Cabaletta Bio | 297.23M |
| Context Therapeutics | 292.18M |
| AC Immune | 291.07M |
| Immix Biopharma | 287.76M |
| Crescent Biopharma | 287.69M |